ICYMI: Una Nueva Encuesta Busca Respuestas Sobre Cómo COVID-19 Está Afectando a Pacientes con Enfermedades Raras en los Estados Unidos

Por Natalie Homan de In The Cloud Copy En los Estados Unidos, una enfermedad se considera "rara" si afecta a menos de 200,000 Estadounidenses en un momento dado. Las enfermedades…

Continue Reading ICYMI: Una Nueva Encuesta Busca Respuestas Sobre Cómo COVID-19 Está Afectando a Pacientes con Enfermedades Raras en los Estados Unidos
Arimoclomol Receives the Fast Track Designation for the Treatment of ALS
source: pixabay.com

Arimoclomol Receives the Fast Track Designation for the Treatment of ALS

CytRx Corporation has recently received the Fast Track designation for their ALS treatment, arimoclomol. This status was also given for the treatment of Niemann-Pick disease and sporadic Inclusion Body Myositis…

Continue Reading Arimoclomol Receives the Fast Track Designation for the Treatment of ALS
This Skin Patch was Able to Improve Motor Function in Advanced Parkinson’s Disease
source: pixabay.com

This Skin Patch was Able to Improve Motor Function in Advanced Parkinson’s Disease

According to a story from Parkinson's News Today, ropinirole (marketed as Requip) skin patches proved capable of improving motor function in patients with advanced Parkinson's disease when compared to placebo.…

Continue Reading This Skin Patch was Able to Improve Motor Function in Advanced Parkinson’s Disease
TNF Inhibitors Increase Risk of Central Nervous System Inflammation for Patients with Autoimmune Disorders
mohamed_hassan / Pixabay

TNF Inhibitors Increase Risk of Central Nervous System Inflammation for Patients with Autoimmune Disorders

According to MedScape, tumor necrosis factor (TNF) inhibitors present severe issues for patients with autoimmune disorders. In particular, patients exposed to TNF inhibitors may experience inflammation throughout their central nervous…

Continue Reading TNF Inhibitors Increase Risk of Central Nervous System Inflammation for Patients with Autoimmune Disorders